Skip to main content
ABSI logo

Absci Corporation

ABSINASDAQHealthcareBiotechnology

$8.88Today:- (-)1Y +82.34%

As of Oct 15, 2026 close

Market cap
$1.40B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.24$12.06
Volume (live)
-
Avg. volume (3M)
4.00M

Absci (ABSI) Income Statement

Absci reported revenue of $2.80M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 38.2% from $4.53M a year earlier. Absci posted a net loss of $115.18M, compared with a net loss of $103.11M a year earlier. Gross margin was -319.4% and operating margin -4454.2%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $318.00K, down 46.4% from the same quarter a year earlier.

Absci Income Statement Analysis

Values in millions USD

Scroll to see more
Absci Corporation income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Revenue & Gross Profit
Revenue2.804.535.725.754.784.782.06
Cost of Revenue11.7462.4647.5758.9144.5911.450.00
Gross Profit-8.944.53-41.85-53.16-39.80-6.672.06
Operating Expenses
Research & Development81.4263.8648.0758.9144.5911.454.31
Selling, General & Administrative35.0636.1737.830.000.005.503.52
Operating Expenses115.78113.4299.9053.5935.436.638.33
Operating Income-124.72-108.89-94.18-106.75-75.24-13.30-6.27
Other Income/Expense
Interest Income0.007.320.000.000.000.000.00
Interest Expense0.210.571.010.973.430.630.27
Other Income/Expense9.606.42-15.281.39-34.62-1.05-0.32
Income
Income Before Tax-115.11-103.04-110.47-105.37-109.86-14.35-6.58
Income Tax Expense0.070.070.10-0.46-8.900.000.00
Net Income-115.18-103.11-110.57-104.90-100.96-14.35-6.58
Net Income - Continuous Operations-115.18-103.11-110.57-104.90-100.96-14.35-6.58
Net Income - Discontinued Operations-------
EBITDA-103.16-89.08-95.46-91.36-67.68-12.59-5.83
EBIT-114.91-102.47-109.46-104.39-106.43-13.30-
Depreciation & Amortization11.7413.3914.0013.046.651.130.49
Earnings Per Share
Basic EPS-1.00-1.00-1.00-1.00-1.00-1.00-
Diluted EPS-1.00-1.00-1.00-1.00-1.00-1.00-
Basic Shares Outstanding136.78110.2492.0390.8592.6592.2592.25
Diluted Shares Outstanding136.78110.2492.0390.8592.6592.2592.25

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Absci Financial Statements

What was Absci's revenue in fiscal 2025?

Absci reported revenue of $2.80M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 38.2% from $4.53M a year earlier.

Is Absci profitable?

No. Absci reported a net loss of $115.18M in fiscal 2025. In fiscal 2024 it lost $103.11M.

What is Absci's operating margin?

Absci's operating income was −$124.72M on revenue of $2.80M in fiscal 2025, an operating margin of -4454.2%, compared with -2401.6% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition